Jiaojiao L. Yuan

Ningbo, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Successful Treatment of Primary Poor Graft Function After Haploidentical Hematopoietic Stem Cell Transplantation With Low-Dose Decitabine Followed by Donor Lymphocyte Infusion and Eltrombopag.

Successful Treatment of Primary Poor Graft Function After Haploidentical Hematopoietic Stem Cell Transplantation With Low-Dose Decitabine Followed by Donor Lymphocyte Infusion and Eltrombopag.

Journal: Cancer medicine
Published: May 21, 2025

Prognostic value of Day 14 measurable residual disease in acute myeloid leukemia treated with venetoclax and azacitidine.

Prognostic value of Day 14 measurable residual disease in acute myeloid leukemia treated with venetoclax and azacitidine.

Journal: Cancer
Published: May 16, 2025

Efficacy and safety of etoposide + cytarabine + pegfilgrastim mobilization regimen versus G-CSF mobilization regimen alone for hematopoietic stem cell mobilization in patients with multiple myeloma and lymphoma.

Efficacy and safety of etoposide + cytarabine + pegfilgrastim mobilization regimen versus G-CSF mobilization regimen alone for hematopoietic stem cell mobilization in patients with multiple myeloma and lymphoma.

Journal: Cytotherapy
Published: March 11, 2025

Venetoclax combined with azacitidine in elderly acute myeloid leukemia: A retrospective comparison of 14-day vs 28-day dosing regimens.

Venetoclax combined with azacitidine in elderly acute myeloid leukemia: A retrospective comparison of 14-day vs 28-day dosing regimens.

Journal: Medicine
Published: March 04, 2025

High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.

High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.

Journal: Biochemical genetics
Published: October 09, 2024

High expression of EBP is an adverse prognostic factor for de novo acute myeloid leukemia.

High expression of EBP is an adverse prognostic factor for de novo acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 01, 2024

Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients.

Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients.

Journal: Annals of hematology
Published: January 24, 2024

Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.

Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.

Journal: Cytotherapy
Published: February 15, 2023

Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.

Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.

Journal: Annals of hematology
Published: January 15, 2023

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: December 02, 2022

Anti-escaping of incident laser in rare-earth doped fluoride ceramics with glass forming layer.

Anti-escaping of incident laser in rare-earth doped fluoride ceramics with glass forming layer.

Journal: Scientific reports
Published: September 17, 2019

Clinical features and prognosis of acute myeloid leukemia with acquired trisomy 21

Clinical features and prognosis of acute myeloid leukemia with acquired trisomy 21

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: August 05, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026